Butobarbitalduring pregnancy and lactation, Butobarbital category by FDA, its use during pregnancy and lactation its teratogenic effects are described.
Small amount of drug excrete into breast milk, if required low dose should be prescribed.
| Butobarbital during pregnancy and lactation | |
| Pregnancy | Category C ( by FDA ) |
| | Butobarbital animals have revealed adverse effects on the fetus (teratogenic or embryocidal, or other) and there are no controlled studies in women or studies in women and animals are not available. |
| Breast feeding | Butobarbital excreted into breast milk, use with caution. |
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.